CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 449 enrolled
Drug / intervention
Perceptions and attitudes towards COVID-19 and COVID-19 vaccineother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05532592
NCT05532592N/ACompleted
CompareCT.gov

Investigation on the Hesitancy of COVID-19 Vaccination Among Liver Transplant Recipients in China

RenJi Hospital·observational·Posted Sep 8, 2022·Updated Sep 8, 2022

In Brief

An observational study evaluating Perceptions and attitudes towards COVID-19 and COVID-19 vaccine for Vaccine Hesitancy. Completed, enrolled 449 participants across 1 site.

Detailed Summary

On WeChat platform, through a point-to-point connection, and carry on the questionnaire survey to collect information of liver transplant recipients followed-up by the department of Liver Surgery, Renji Hospital Shanghai Jiao Tong University. Patients meeting inclusion and exclusion criteria will be selected. Conduct statistical analysis to describe the incidence of adverse reactions related to COVID-19 vaccine after liver transplantation, and to compare and evaluate the factors leading to COVID-19 vaccine hesitancy.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsVaccine Hesitancy
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedSep 8, 2022
Enrollment StartApr 27, 2022
Primary CompletionMay 10, 2022
Study CompletionMay 30, 2022
TodayJul 2, 2026
Enrollment to primary: 13 daysPosted 3.8 years ago

Interventions

Perceptions and attitudes towards COVID-19 and COVID-19 vaccineother

Attitude towards COVID-19; Knowledge about COVID-19 vaccine